Cargando…

Mechanisms of potentiation of Angiotensin II-induced contractile response of isolated rat aorta by hydrogen peroxide and tert-butyryl hydroperoxide

OBJECTIVE: To study the mechanism involved in hydrogen peroxide (H(2)O(2)) or tert-butyl hydroperoxide (t-BHP)-induced potentiation of the Ang II-mediated contraction of isolated rat thoracic aorta. MATERIALS AND METHODS: Thoracic aorta was isolated from the Sprauge dawley rats (300–320 gm), cut spi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, R. J., Patel, P. D., Patel, M. M., Patel, N. J., Thyagarajan, B.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861816/
https://www.ncbi.nlm.nih.gov/pubmed/20442823
http://dx.doi.org/10.4103/0253-7613.55208
Descripción
Sumario:OBJECTIVE: To study the mechanism involved in hydrogen peroxide (H(2)O(2)) or tert-butyl hydroperoxide (t-BHP)-induced potentiation of the Ang II-mediated contraction of isolated rat thoracic aorta. MATERIALS AND METHODS: Thoracic aorta was isolated from the Sprauge dawley rats (300–320 gm), cut spirally and response to Ang II (5 × 10(−8)M) was taken in the absence and presence of H(2)O(2) (10(−6)M) and t-BHP (10(−5)M). To explore the probable mechanism of H(2)O(2) and t-BHP-induced potentiation of Ang II-mediated contractile response, different blockers such as losartan (AT(1) receptor blocker; 1 μM), catalase (H(2)O(2) scavenger; 500 U/ml), lercanidipine (L-type calcium channel blocker; 1 μM), geinistein (tyrosine kinase inhibitor; 100 μM), and indomethacin (cyclo-oxygenase inhibitor; 10 μM) were used. RESULTS: In spiral preparation of rat thoracic aorta, H(2)O(2) (10(−6)M) and t-BHP (10(−5)M) did not produce the contraction as such. However, when they are added simultaneously with Ang II (5 × 10(−8) M), they potentiated the contractile response of the Ang II. Catalase (500 U/ml) partially antagonized the Ang-II-induced contraction, as well as antagonized the potentiation induced by H(2)O(2). Losartan (1 μM) and lercanidipine (1 μM) antagonized the Ang II-induced contractile response without affecting H(2)O(2) (10(−6)M)-mediated potentiation. Geinistein (100 μM) antagonized H(2)O(2) (10(−6)M)-mediated potentiation, but it slightly decreased the Ang II response. Losartan (1 μM) and lercanidipine (1 μM) and Geinistein (100 μM) antagonized the Ang II-induced contractile response but not t-BHP-mediated potentiation. Indomethacin antagonized t-BHP-mediated potentiation without affecting much of Ang II response. CONCLUSION: From the above-mentioned results, we can reasonably conclude that H(2)O(2) and t-BHP potentiated the contraction induced by the Ang II. H(2)O(2)-induced potentiation of Ang II response may be mediated through tyrosine kinase activation and t-BHP through the activation of cyclo-oxygenase enzyme.